$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024098382 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$659.9K
YoY Change		-18.93%
Cost Of Revenue		$381.8K
YoY Change		10.14%
Gross Profit		$278.1K
YoY Change		-40.49%
Gross Profit Margin		42.15%
Selling, General & Admin		$630.0K
YoY Change		10.53%
% of Gross Profit		226.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$26.08K
YoY Change		30.4%
% of Gross Profit		9.38%
Operating Expenses		$641.2K
YoY Change		10.17%
Operating Profit		-$363.1K
YoY Change		216.72%
Interest Expense		-$88.45K
YoY Change		-250.71%
% of Operating Profit
Other Income/Expense, Net		-$309.7K
YoY Change		526.39%
Pretax Income		-$672.7K
YoY Change		320.46%
Income Tax
% Of Pretax Income
Net Earnings		-$672.7K
YoY Change		310.03%
Net Earnings / Revenue		-101.95%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00
COMMON SHARES
Basic Shares Outstanding	596.3M shares	550.5M shares
Diluted Shares Outstanding		545.3M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$21.67K
YoY Change		-98.08%
Cash & Equivalents		$21.67K
Short-Term Investments
Other Short-Term Assets		$86.44K
YoY Change		188.13%
Inventory		$146.4K
Prepaid Expenses
Receivables		$226.6K
Other Receivables		$21.96K
Total Short-Term Assets		$586.6K
YoY Change		-62.13%
LONG-TERM ASSETS
Property, Plant & Equipment		$176.5K
YoY Change		-4.0%
Goodwill		$350.5K
YoY Change		0.0%
Intangibles		$191.5K
YoY Change		-20.87%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$831.8K
YoY Change		-12.37%
TOTAL ASSETS
Total Short-Term Assets		$586.6K
Total Long-Term Assets		$831.8K
Total Assets		$1.418M
YoY Change		-43.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$812.6K
YoY Change		12.14%
Accrued Expenses		$379.5K
YoY Change		-6.53%
Deferred Revenue		$130.5K
YoY Change		-4.38%
Short-Term Debt		$654.1K
YoY Change		-36.5%
Long-Term Debt Due		$271.6K
YoY Change		239.55%
Total Short-Term Liabilities		$2.373M
YoY Change		-15.98%
LONG-TERM LIABILITIES
Long-Term Debt		$1.829M
YoY Change		2948.73%
Other Long-Term Liabilities		$53.04K
YoY Change		-51.78%
Total Long-Term Liabilities		$1.882M
YoY Change		987.55%
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.373M
Total Long-Term Liabilities		$1.882M
Total Liabilities		$4.255M
YoY Change		41.96%
SHAREHOLDERS EQUITY
Retained Earnings		-$62.09M
YoY Change		3.77%
Common Stock		$545.3K
YoY Change		2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$4.988M
YoY Change
Total Liabilities & Shareholders Equity		$1.418M
YoY Change		-43.22%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$672.7K
YoY Change		310.03%
Depreciation, Depletion And Amortization		$26.08K
YoY Change		30.4%
Cash From Operating Activities		-$324.5K
YoY Change		1.4%
INVESTING ACTIVITIES
Capital Expenditures		$42.16K
YoY Change		-61.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$42.16K
YoY Change		-61.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		192.0K
YoY Change		219.97%
NET CHANGE
Cash From Operating Activities		-324.5K
Cash From Investing Activities		-42.16K
Cash From Financing Activities		192.0K
Net Change In Cash		-174.6K
YoY Change		-52.8%
FREE CASH FLOW
Cash From Operating Activities		-$324.5K
Capital Expenditures		$42.16K
Free Cash Flow		-$366.6K
YoY Change		-14.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53029
	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2029 Pat Booker Rd
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Antonio
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78148
	dei	City Area Code CityAreaCode	210
	dei	Local Phone Number LocalPhoneNumber	490-3977
	dei	Security12b Title Security12bTitle	N/A
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	596301757	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21673	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226645	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	146437	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	86444	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28503	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	83485	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2400	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	586645	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1373118	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	176536	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	113205	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191537	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q3	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	831769	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	909995	usd
CY2024Q3	us-gaap	Assets Assets	1418414	usd
CY2023Q4	us-gaap	Assets Assets	2283113	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	654050	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	271636	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	812579	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	710222	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	379478	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	474515	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	64557	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	717204	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	130458	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	500720	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60166	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2372924	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2725072	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	783091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	1046146	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53039	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1882276	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1057449	usd
CY2024Q3	us-gaap	Liabilities Liabilities	4255200	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3782521	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	545253623	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	545253623	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532818051	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532818051	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	545254	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	532818	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56561018	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55852477	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62094359	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60851714	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4988087	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4466419	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	119077	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	141884	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4869010	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1418414	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2283113	usd
CY2024Q3	us-gaap	Revenues Revenues	659881	usd
CY2023Q3	us-gaap	Revenues Revenues	813951	usd
	us-gaap	Revenues Revenues	2460218	usd
	us-gaap	Revenues Revenues	1743226	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	381773	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	346611	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1268661	usd
	us-gaap	Cost Of Revenue CostOfRevenue	801042	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	278108	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	467340	usd
	us-gaap	Gross Profit GrossProfit	1191557	usd
	us-gaap	Gross Profit GrossProfit	942184	usd
CY2024Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	403517	usd
CY2023Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	308991	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1556184	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1177044	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	86814	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	111005	usd
	us-gaap	Professional Fees ProfessionalFees	316428	usd
	us-gaap	Professional Fees ProfessionalFees	491958	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	150836	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	161975	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	515884	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	483279	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	641167	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	581971	usd
	us-gaap	Operating Expenses OperatingExpenses	2388496	usd
	us-gaap	Operating Expenses OperatingExpenses	2152281	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4051709	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-363059	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-114631	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1196939	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2841612	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-221220	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9250	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	126770	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	471831	usd
CY2024Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	88450	usd
CY2023Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	58301	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	156177	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	420276	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	386	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6049	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-309670	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-49437	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29407	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	45506	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-672729	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
	us-gaap	Profit Loss ProfitLoss	-1226346	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-36524	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28657	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-22807	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6705	usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	11008	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	13483	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	39106	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	40788	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-647213	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1242645	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	545253623	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	541386297	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	545253623	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524747583	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	541386297	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2355294011	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	40000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	127640	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	14349	usd
CY2024Q1	cbnt	Adjustment To Additional Paid In Capital Beneficialconversionchargeforissuanceof Series Bpreferredsharesforaccruedcompensation AdjustmentToAdditionalPaidInCapitalBeneficialconversionchargeforissuanceofSeriesBpreferredsharesforaccruedcompensation	326968	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4151924	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	206369	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13749	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-245969	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4185273	usd
CY2024Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	11008	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-672729	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4869010	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	40000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	101400	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13687	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	39450	usd
CY2023Q2	cbnt	Common Stock Issued For Compensations CommonStockIssuedForCompensations	26000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	82600	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Conversion Of Debt Accrued Interest And Fees StockIssuedDuringPeriodValueForConversionOfDebtAccruedInterestAndFees	200389	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13618	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4046	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167766	usd
CY2023Q3	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	4500	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	30000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13483	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3310817	usd
	us-gaap	Profit Loss ProfitLoss	-1226346	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75104	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63953	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	48705	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	96075	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	2250	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	376968	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	119700	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	126770	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	471831	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4051709	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	732	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	660	usd
	cbnt	Noncash Compensation Claw Back NoncashCompensationClawBack	-21961	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7021	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10331	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-190425	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8970	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-35226	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42388	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	57941	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	734	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	81085	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-279	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	102357	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55162	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-95143	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	23285	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-9641	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	6450	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	26041	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-370262	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	113790	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1136520	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1228280	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42157	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	114770	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4042631	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42157	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3927861	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	775837	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	291621	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	176948	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1807414	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	250000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	135000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	222750	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	463889	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1663543	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-714788	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1036038	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21673	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1133129	usd
	us-gaap	Interest Paid Net InterestPaidNet	124558	usd
	us-gaap	Interest Paid Net InterestPaidNet	225739	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	83950	usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	78000	usd
	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	312000	usd
	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	144000	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	39106	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	40788	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	60000	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	214000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	198139	usd
	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital	334009	usd
	cbnt	Reclassification Of Series C Preferred To Notes Payable ReclassificationOfSeriesCPreferredToNotesPayable	800000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	284408	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Prior to May 8, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShield<sup>TM</sup> product line and related technologies were sold (see Note 16), the Company has operated in one segment. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry-resistant system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the Exchange Agreement as amended, or the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending at 5:00 P.M. EST on the date that is 30 calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield<sup>TM</sup> division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</p>
CY2023Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Profit Loss ProfitLoss	-1226346	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1136520	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1228280	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62094359	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4869010	usd
CY2024Q3	cbnt	Working Capital WorkingCapital	1786279	usd
CY2024Q3	us-gaap	Cash Cash	21673	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the nine months ended September 30, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Advertising Expense AdvertisingExpense	48344	usd
	us-gaap	Advertising Expense AdvertisingExpense	27242	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-647213	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1242645	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	545253623	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	541386297	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-647213	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1242645	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	40788	usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	138837	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-647213	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-206208	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1242645	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3032660	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	545253623	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	541386297	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	545253623	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524747583	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	541386297	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2355294011	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2014209631	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1919036011	shares
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk and Uncertainties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.</p>
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	271409	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	459414	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44764	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35323	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226645	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7021	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	10331	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	146437	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	181663	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	146437	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	296324	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119788	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82561	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	176536	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
	us-gaap	Depreciation Depreciation	37227	usd
	us-gaap	Depreciation Depreciation	26075	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	160979	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	123102	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191537	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q3	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37877	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37878	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	41034	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	91537	usd
CY2024Q3	cbnt	Outstanding Principal Balance Rate OutstandingPrincipalBalanceRate	1.25	pure
CY2024Q3	cbnt	Accrued Interest Rate Per Anum AccruedInterestRatePerAnum	0.18	pure
	cbnt	Debt Instrument Trading Days DebtInstrumentTradingDays	P10D
CY2024Q3	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.50	pure
	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2023Q4	cbnt	Aggregate Payment AggregatePayment	1113091	usd
	cbnt	Gross Proceeds GrossProceeds	0.20	pure
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	120000	usd
CY2023Q4	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15000	usd
CY2024Q1	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.20	pure
CY2024Q2	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.15	pure
CY2024Q3	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.10	pure
CY2024Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	176184	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2024Q1	cbnt	Original Issue Discount Percentage OriginalIssueDiscountPercentage	0.35	pure
CY2024Q3	cbnt	Outstanding Principal Percentage OutstandingPrincipalPercentage	2.20	pure
CY2024Q2	cbnt	Original Issue Discount Percentage OriginalIssueDiscountPercentage	0.35	pure
CY2024Q2	cbnt	Outstanding Principal Balance Rate OutstandingPrincipalBalanceRate	2.20	pure
CY2024Q2	cbnt	Percentage Of Outstanding Shares Common Stock PercentageOfOutstandingSharesCommonStock	0.0499	pure
CY2024Q2	cbnt	Net Of Original Issue Amount NetOfOriginalIssueAmount	50000	usd
CY2024Q2	cbnt	Original Issue Discounts OriginalIssueDiscounts	17500	usd
CY2024Q2	cbnt	Original Issue Discount Percentage OriginalIssueDiscountPercentage	0.35	pure
CY2024Q2	cbnt	Percentage Of Outstanding Shares Common Stock PercentageOfOutstandingSharesCommonStock	0.0499	pure
CY2024Q3	cbnt	Original Issue Discount Percentage OriginalIssueDiscountPercentage	0.35	pure
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	189642	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	1247499	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	1098091	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	189642	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1437141	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	654050	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	783091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1326776	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	124781	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8994	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	764	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	1317782	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	124017	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	271636	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	81908	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1046146	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	42109	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	200000	usd
CY2024Q3	cbnt	Cash Proceeds CashProceeds	190000	usd
CY2024Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	800000	usd
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	14850	usd
CY2024Q3	cbnt	Principal Amount Due PrincipalAmountDue	97407	usd
CY2024Q2	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	8775	usd
CY2024Q2	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.35	pure
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	317293	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	998008	shares
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	160880	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	cbnt	Maturity Terms MaturityTerms	P12M
CY2022Q3	cbnt	Common Stock Trading Price Per Share CommonStockTradingPricePerShare	0.009
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	93448	usd
	cbnt	Preferred Stock Convertible Conversion Percentage PreferredStockConvertibleConversionPercentage	1	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.059
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	95161	usd
CY2024Q1	cbnt	Compensation Stated Value CompensationStatedValue	50000	usd
CY2024Q1	cbnt	Initial Conversion Closing Price InitialConversionClosingPrice	0.0031
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.059
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	6131037	shares
CY2024Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
	cbnt	Accrued Dividends AccruedDividends	19754	usd
	cbnt	Accrued Dividends AccruedDividends	23792	usd
CY2024Q3	cbnt	Preferred Stock Stated Value PreferredStockStatedValue	655000	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	125914	usd
CY2023	cbnt	Preferred State Value Inclued Liquidations PreferredStateValueIncluedLiquidations	1515000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	275000	shares
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	cbnt	Stock Issued During Period Shares For Accrued Compensation StockIssuedDuringPeriodSharesForAccruedCompensation	9636364	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22500	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q2	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	22500	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16950	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0011
CY2023Q2	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	16950	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1000000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4500	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42183	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2024Q1	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	5781562	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	200	shares
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	6131037	shares
CY2024Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	200	shares
CY2024Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
	cbnt	Voting Percentage VotingPercentage	0.10	pure
	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	50000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	120	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	5250000	shares
CY2017Q4	cbnt	Annual Base Salary AnnualBaseSalary	300000	usd
CY2017Q4	cbnt	Annual Base Salary Rate AnnualBaseSalaryRate	0.10	pure
CY2017Q4	cbnt	Debt Or Equity Financing DebtOrEquityFinancing	1000000	usd
CY2017Q4	cbnt	Capital Raise Rate CapitalRaiseRate	0.05	pure
CY2017Q4	cbnt	Common Stock Shares Acquired CommonStockSharesAcquired	3000000	shares
CY2017Q4	cbnt	Common Stock Shares Acquired Per Share CommonStockSharesAcquiredPerShare	0.31
CY2017Q4	cbnt	Stock Options Shares Issued StockOptionsSharesIssued	500000	shares
CY2017Q4	cbnt	Strike Price StrikePrice	0.85
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2021Q3	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2023	cbnt	Bonus Percentage BonusPercentage	0.10	pure
CY2023	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	162000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	312000	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	312	shares
CY2016Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.85
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
	cbnt	Issued Percentage IssuedPercentage	0.20	pure
	cbnt	Outstanding Percentage OutstandingPercentage	0.20	pure
	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
	cbnt	Option Period Percentage OptionPeriodPercentage	0.20	pure
CY2023Q3	cbnt	Share Value Percentage ShareValuePercentage	3	pure
CY2023Q4	cbnt	Nonrefundable Cash Fee NonrefundableCashFee	25000	usd
CY2023Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.065	pure
CY2023Q4	cbnt	Break Up Fee Percentage BreakUpFeePercentage	0.10	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2024Q3	us-gaap	Revenues Revenues	659881	usd
CY2023Q3	us-gaap	Revenues Revenues	813951	usd
	us-gaap	Revenues Revenues	2460218	usd
	us-gaap	Revenues Revenues	1743226	usd
CY2024Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	26089	usd
CY2023Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	22558	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	75104	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	63953	usd
CY2024Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	88450	usd
CY2023Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	58687	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	156177	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	426325	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-672729	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
	us-gaap	Profit Loss ProfitLoss	-1226346	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	176536	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2460218	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1743226	usd
CY2019Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P18M
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2021Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2022	us-gaap	Payments For Rent PaymentsForRent	5283	usd
	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	16800	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	84701	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.115	pure
CY2024Q3	cbnt	Office Leases And Office Equipment Right Of Use Assets OfficeLeasesAndOfficeEquipmentRightOfUseAssets	279162	usd
CY2023Q4	cbnt	Office Leases And Office Equipment Right Of Use Assets OfficeLeasesAndOfficeEquipmentRightOfUseAssets	279162	usd
CY2024Q3	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	165957	usd
CY2023Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	120678	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	113205	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	113205	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157752	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60166	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53039	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	70351	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	56000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	126351	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13146	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	113205	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	175000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	4000000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1989755	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating		usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	cbnt	Stockbased Professional Fees stockbasedProfessionalFees		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	cbnt	Noncash Compensation Claw Back NoncashCompensationClawBack		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices		usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital		usd
	cbnt	Reclassification Of Series C Preferred To Notes Payable ReclassificationOfSeriesCPreferredToNotesPayable		usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2024Q3	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
CY2023Q3	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
CY2024Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium		usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
0001213900-24-098382-index-headers.html	Edgar Link	pending
0001213900-24-098382-index.html	Edgar Link	pending
0001213900-24-098382.txt	Edgar Link	pending
0001213900-24-098382-xbrl.zip	Edgar Link	pending
cbnt-20240930.xsd	Edgar Link	pending
ea0220620-10q_cbond.htm	Edgar Link	pending
ea022062001ex31-1_cbond.htm	Edgar Link	pending
ea022062001ex31-2_cbond.htm	Edgar Link	pending
ea022062001ex32-1_cbond.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
cbnt-20240930_cal.xml	Edgar Link	unprocessable
cbnt-20240930_def.xml	Edgar Link	unprocessable
cbnt-20240930_lab.xml	Edgar Link	unprocessable
cbnt-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0220620-10q_cbond_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2024 Q4 Form 10-Q Financial Statement

#000121390024098382 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2024 Q4 Form 10-Q Financial Statement

#000121390024098382 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt